Similar Posts
XAU/USD: Elliott wave analysis and forecast for 15.08.25 – 22.08.25 | LiteFinance
BySilas W2025.08.15 2025.08.15 XAU/USD: Elliott Wave Analysis and Forecast for 15.08.25 – 22.08.25 Alex Geutahttps://www.litefinance.org/blog/authors/alex-geuta/ The article covers the following subjects: Major Takeaways Main scenario: Consider short positions from corrections below the level of 3,410.00 with a bearish target of 3,120.00 – 2,950.00. A sell signal: the price holds below 3,410.00. Stop Loss: above 3,440.00, Take…
After tariffs, the focus will go back to the Fed and the inflation problem | Forexlive
BySilas WIn last month’s fresh set of FOMC forecasts, the median on PCE inflation was 2.7% with a range of 2.5-3.4%. They may need a re-think. Ed Bradford highlights that one-year inflation swaps are now above 3.3% and already at the high end of the Fed’s forecasts. Now much of that is pricing in an uncertain…
UBS: Renata Jungo Brüngger and Lila Tretikov to Be Nominated to Board of Directors
BySilas WUBS announced the nominations of Renata Jungo Brüngger and Lila Tretikov for election to its Board of Directors at the bank’s upcoming Annual General Meeting on 10 April 2025. Jungo Brüngger, currently a member of the Board of Management at Mercedes-Benz Group AG, brings extensive experience in legal affairs, governance, and sustainability. She oversees integrity,…
new truck, new crew « Blog InstaForex
BySilas WAles Loprais opens a new chapter in his Dakar Rally career. The Czech driver is moving on from the Praga V4S DKR, which secured him a remarkable second place in this year’s legendary race, to the cockpit of an Iveco Powerstar. But the change is not limited to his car. Loprais’ crew is also undergoing…
Novartis provides update on Phase III GCAptAIN study of Cosentyx® in giant cell arteritis (GCA)
BySilas WThe GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1 Safety in GCA patients was consistent with known safety profile of Cosentyx® (secukinumab)1 Basel, July 03, 2025 – Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab)…
Daily Routine of a Successful Forex Trader: Tips for Staying Disciplined – Forexblogger.com.ng
BySilas WSticking to a routine might sound boring, but for forex traders, it’s the secret to success. When you develop a daily rhythm, you become more consistent, make smarter decisions, and protect your profits. Staying disciplined helps you avoid emotional trades that can wipe out your gains. Building a solid routine creates a mindset where trading…

